Cells are intricate and bustling microcosms, relying on specialized compartments known as organelles to perform critical biological functions. Just like our body’s heart or liver, these cellular organelles regulate nutrient transport, waste removal, and gene expression. While some organelles are enclosed by membranes, others exist as membrane-less, dynamic structures called biomolecular condensates—droplet-like clusters of proteins and RNA that transiently assemble to optimize biochemical reactions. Recently, UCLA scientists have pioneered an innovative method to engineer these biomolecular condensates using programmable RNA, offering unprecedented control over cell compartmentalization and function.
Traditional synthetic biology approaches have largely depended on protein-based mechanisms to form artificial organelles. However, these methods pose challenges in precise programmability and cellular resource demands. The UCLA team’s breakthrough hinges on using RNA not only as a genetic blueprint but also as the structural building material to create highly customizable, artificial organelles within living mammalian cells. Their research, published in Nature Nanotechnology on April 29, 2026, showcases the capacity to engineer RNA molecules that self-assemble into discrete condensates, spatially and functionally tailored for specific intracellular applications.
At the heart of this approach are specially designed short RNA strands, termed “nanostars,” which fold into star-shaped structures with multiple arms. Each arm is capped with complementary “kissing loops” — short RNA sequences with the intrinsic ability to bind selectively with their counterpart loops on other nanostars. This molecular “handshake” guides the self-assembly of RNA nanostars into larger, networked condensates with programmable architectures and properties. This RNA-based modularity surpasses natural biomolecular condensate complexity by offering predictable and tunable interaction rules based on RNA base pairing principles.
The ability to dictate when, where, and how these RNA condensates form within cells is a crucial advance. By fine-tuning parameters such as the number of arms per nanostar, the length of connecting RNA segments, and the binding affinity between kissing loops, the researchers could control condensate localization between the cytoplasm and nucleus. These spatially distinct compartments enable distinct biochemical microenvironments, emulating specialized cellular “rooms” designed to sequester or concentrate molecular machinery tailored for unique biological functions.
Elisa Franco, the senior author and UCLA professor of mechanical and aerospace engineering and bioengineering, emphasized the broader implications of RNA-based condensate engineering. She highlighted that RNA offers a leaner and more resource-efficient scaffold compared to protein-based systems, reducing metabolic burdens on the host cell while expanding the toolbox for cellular interior design. This bioengineering leap potentially opens new avenues in synthetic biology, allowing cells to be architecturally programmed with tailor-made compartments that enhance and diversify cellular functions including gene regulation, metabolic control, and response to environmental stimuli.
The functional versatility of these programmable condensates lies in their capacity to selectively recruit specific biomolecules. By designing nanostars to display molecular “addresses,” these condensates can attract enzymes, RNA-binding proteins, or regulatory factors, creating isolated reaction hubs. This selective recruitment reinforces the concept of synthetic organelles acting as dedicated biochemical workstations that enable spatial coordination of complex cellular pathways, thereby improving efficiency and specificity of molecular interactions.
Beyond fundamental cell biology, this RNA condensate technology holds significant translational promise. In nanomedicine, synthetic organelles could be harnessed to package and release therapeutic molecules intracellularly with high precision. In genetics and cell engineering, they offer a platform for orchestrating gene expression networks with spatial and temporal resolution previously unattainable. Moreover, artificial RNA condensates might facilitate the development of bio-computational devices within living cells, using designed RNA assemblies as programmable logic gates or signal processors.
The study enlisted a multidisciplinary team spanning bioengineering, cell biology, and molecular genetics, spearheaded by researchers including Shiyi Li, a doctoral candidate focusing on RNA design and condensate dynamics. Collaboration with experts from UCLA’s Stem Cell Research Center and Microbiology departments enriched the project’s biological and technological scope. The group’s collective expertise was instrumental in validating condensate formation and demonstrating their programmability in live mammalian cells, providing compelling experimental evidence for synthetic biomolecular engineering.
Rigorous experimental methodologies were employed to visualize and characterize the RNA condensates. Advanced fluorescence microscopy and molecular tagging techniques confirmed spatial localization patterns and dynamic assembly kinetics of condensates in live cells. Quantitative analyses elucidated how altering nanostar structural parameters modulated condensate size and composition. These insights deepen understanding of RNA-mediated phase separation phenomena and reinforce the concept of biomolecular condensates as programmable, reconfigurable intracellular entities.
An important aspect of this work is the translation of molecular design principles into user-defined structural outcomes within a complex cellular environment. The study demonstrated that designer RNA nanostars obey predictable base-pairing and tertiary interaction rules, allowing researchers to underpin condensate formation on rational sequence engineering. This strategy marks a paradigm shift from relying on naturally aggregation-prone proteins to utilizing fully programmable nucleic acid assemblies that can be custom-tailored for any desired biological role or interaction specificity.
Funding sources supporting this pioneering research include the U.S. National Science Foundation, the Alfred P. Sloan Foundation, and the National Institutes of Health, reflecting the high scientific and translational value of this work. Additionally, the UCLA Technology Development Group has taken measures to protect the intellectual property associated with these innovations through patent filings. This underscores both the novelty and potential commercial impact of programmable artificial RNA organelles as next-generation synthetic biology tools.
As this field advances, ongoing research aims to expand the repertoire of RNA nanostructures to mimic more complex organelle features, enhancing functionality and stability. Integration of RNA condensates with endogenous cellular pathways will be critical to realize their full therapeutic and biotechnological potentials. The vision of “architecting” the interior of living cells using RNA modular components positions this work at the cutting edge of synthetic biology, promising a future where cells can be custom-engineered with designable internal landscapes for health, energy, and environmental applications.
Subject of Research: Cells
Article Title: Programmable artificial RNA condensates in mammalian cells
News Publication Date: 29-Apr-2026
Web References: https://www.nature.com/articles/s41565-026-02164-7
References: DOI 10.1038/s41565-026-02164-7
Image Credits: Dynamic Nucleic Acid Systems Lab/UCLA
Keywords: Organelles, Biotechnology, Synthetic biology, RNA, RNA structure
